Peter Fernandes's most recent trade in Bellerophon Therapeutics Inc was a trade of 100,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc | Peter Fernandes | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 100,000 | 100,000 | - | - | Stock Options (Right to Buy) | |
| Bellerophon Therapeutics Inc | Peter Fernandes | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 100,000 | 100,000 | - | - | Stock Options (right to buy) | |
| Bellerophon Therapeutics Inc | Peter Fernandes | PRINCIPAL EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 32,500 | 32,500 | - | - | Restricted Stock Units | |
| Bellerophon Therapeutics Inc | Peter Fernandes | PRINCIPAL EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 32,500 | 32,500 (0%) | 0% | - | Common Stock | |
| Bellerophon Therapeutics Inc | Peter Fernandes | PRINCIPAL EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 09 Dec 2022 | 9,985 | 22,515 (0%) | 0% | 0.9 | 9,287 | Common Stock |
| Bellerophon Therapeutics Inc | Peter Fernandes | CHIEF REGULATORY & SAFETY OFFR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 65,000 | 65,000 | - | - | Restricted Stock Units |